Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 1537213, 8 pages
https://doi.org/10.1155/2017/1537213
Review Article

Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis

1Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Diabetes Research Center of Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
2Department of Cardiology, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, China

Correspondence should be addressed to Xinhua Xiao; moc.361.piv@4102hxoaix

Received 20 February 2017; Revised 5 June 2017; Accepted 19 June 2017; Published 17 September 2017

Academic Editor: Qian Li

Copyright © 2017 Jia Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Cooper, J. Cutler, P. Desvigne-Nickens et al., “Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention,” Circulation, vol. 102, no. 25, pp. 3137–3147, 2000. View at Publisher · View at Google Scholar
  2. C. L. Leibson and K. M. Narayan, “Trends in cardiovascular complications of diabetes,” The Journal of the American Medical Association, vol. 293, no. 14, p. 1723, 2005. View at Publisher · View at Google Scholar
  3. J. D. Flaherty and C. J. Davidson, “Diabetes and coronary revascularization,” The Journal of the American Medical Association, vol. 293, no. 12, pp. 1501–1508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. C. Gerstein, J. Pogue, J. F. Mann et al., “The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis,” Diabetologia, vol. 48, no. 9, pp. 1749–1755, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Mohammadi, F. Dagenais, P. Mathieu et al., “Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery,” Circulation, vol. 116, 11 Supplement, pp. I220–I225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Rajakaruna, C. A. Rogers, C. Suranimala, G. D. Angelini, and R. Ascione, “The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis,” The Journal of Thoracic and Cardiovascular Surgery, vol. 132, no. 4, pp. 802–810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Carson, P. M. Scholz, A. Y. Chen, E. D. Peterson, J. Gold, and S. H. Schneider, “Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery,” Journal of the American College of Cardiology, vol. 40, no. 3, pp. 418–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Liu, J. Han, T. Liu, Z. Yang, H. Jiang, and H. Wang, “The effects of diabetes mellitus in patients undergoing off-pump coronary artery bypass grafting,” BioMed Research International, vol. 2016, Article ID 4967275, 6 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. D. Hillis, P. K. Smith, J. L. Anderson et al., “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 124, no. 23, pp. e652–e735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ishihara, E. Kagawa, I. Inoue et al., “Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era,” The American Journal of Cardiology, vol. 99, no. 12, pp. 1674–1679, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Svensson, D. K. McGuire, P. Abrahamsson, and M. Dellborg, “Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events,” European Heart Journal, vol. 26, no. 13, pp. 1255–1261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hadjadj, D. Coisne, G. Mauco et al., “Prognostic value of admission plasma glucose and HbA in acute myocardial infarction,” Diabetic Medicine, vol. 21, no. 4, pp. 305–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Corpus, P. B. George, J. A. House et al., “Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention,” Journal of the American College of Cardiology, vol. 43, no. 1, pp. 8–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, Supplement 1, pp. S64–S71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kowalczyk, M. Mazurek, T. Zielinska et al., “Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities,” European Journal of Preventive Cardiology, vol. 22, no. 6, pp. 798–806, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Zheng, J. Cheng, Q. Zhang, C. Qi, T. Wang, and X. Xiao, “Association between glycosylated hemoglobin level and cardiovascular outcomes in diabetic patients after percutaneous coronary intervention,” Medicine, vol. 95, no. 19, article e3696, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” BMJ, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar
  18. K. Dickersin and J. A. Berlin, “Meta-analysis: state-of-the-science,” Epidemiologic Reviews, vol. 14, no. 1, pp. 154–176, 1992. View at Publisher · View at Google Scholar
  19. H. Chootrakool, J. Q. Shi, and R. Yue, “Meta-analysis and sensitivity analysis for multi-arm trials with selection bias,” Statistics in Medicine, vol. 30, no. 11, pp. 1183–1198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Sterne, M. Egger, and G. D. Smith, “Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis,” BMJ, vol. 323, no. 7304, pp. 101–105, 2001. View at Publisher · View at Google Scholar
  21. H. Sato, G. Carvalho, T. Sato, R. Lattermann, T. Matsukawa, and T. Schricker, “The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4338–4344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. Halkos, J. D. Puskas, O. M. Lattouf et al., “Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery,” The Journal of Thoracic and Cardiovascular Surgery, vol. 136, no. 3, pp. 631–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Halkos, O. M. Lattouf, J. D. Puskas et al., “Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery,” The Annals of Thoracic Surgery, vol. 86, no. 5, pp. 1431–1437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Knapik, D. Ciesla, K. Filipiak, M. Knapik, and M. Zembala, “Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery,” European Journal of Cardio-Thoracic Surgery, vol. 39, no. 4, pp. 484–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Alserius, R. E. Anderson, N. Hammar, T. Nordqvist, and T. Ivert, “Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery,” Scandinavian Cardiovascular Journal, vol. 42, no. 6, pp. 392–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Santos, R. R. Favaloro, D. Lowenstein, H. Sanabria, H. Raffaelli, and A. Hershson, “Medium-term glycemic control in diabetics before coronary bypass surgery,” Medicina, vol. 75, no. 5, pp. 277–281, 2015. View at Google Scholar
  27. Z. Faritous, M. Ardeshiri, F. Yazdanian, A. Jalali, Z. Totonchi, and R. Azarfarin, “Hyperglycemia or high hemoglobin A1C: which one is more associated with morbidity and mortality after coronary artery bypass graft surgery?” Annals of Thoracic and Cardiovascular Surgery, vol. 20, no. 3, pp. 223–228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Tsuruta, K. Miyauchi, T. Yamamoto et al., “Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting,” Journal of Cardiology, vol. 57, no. 2, pp. 181–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. American Diabetes Association, “Standards of medical care for patients with diabetes mellitus,” Diabetes Care, vol. 25, no. 1, pp. 213–229, 2002. View at Publisher · View at Google Scholar
  30. D. Cheng, Y. Fei, Y. Liu et al., “HbA1C variability and the risk of renal status progression in diabetes mellitus: a meta-analysis,” PLoS One, vol. 9, no. 12, article e115509, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. S. Hillis, B. L. Croal, K. G. Buchan et al., “Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up,” Circulation, vol. 113, no. 8, pp. 1056–1062, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. S. Fox, “Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study,” Trends in Cardiovascular Medicine, vol. 20, no. 3, pp. 90–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. The Emerging Risk Factors Collaboration, N. Sarwar, P. Gao et al., “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies,” Lancet (London, England), vol. 375, no. 9733, pp. 2215–2222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Selvin, S. Marinopoulos, G. Berkenblit et al., “Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus,” Annals of Internal Medicine, vol. 141, no. 6, pp. 421–431, 2004. View at Publisher · View at Google Scholar
  35. H. C. Gerstein, S. Islam, S. Anand et al., “Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study,” Diabetologia, vol. 53, no. 12, pp. 2509–2517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. K. K. Ray, S. R. Seshasai, S. Wijesuriya et al., “Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials,” Lancet, vol. 373, no. 9677, pp. 1765–1772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. B. Buse, H. N. Ginsberg, G. L. Bakris et al., “Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association,” Circulation, vol. 115, no. 1, pp. 114–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Nathan, P. A. Cleary, J. Y. Backlund et al., “Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes,” The New England Journal of Medicine, vol. 353, no. 25, pp. 2643–2653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. E. Kassaian, H. Goodarzynejad, M. A. Boroumand et al., “Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting,” Cardiovascular Diabetology, vol. 11, no. 1, p. 82, 2012. View at Publisher · View at Google Scholar · View at Scopus